SGYP
Synergy Pharmaceuticals, Inc Common Stock
SGYP
SGYP
Delisted
SGYP was delisted on the 7th of March, 2019.
80 hedge funds and large institutions have $142M invested in Synergy Pharmaceuticals, Inc Common Stock in 2014 Q1 according to their latest regulatory filings, with 14 funds opening new positions, 31 increasing their positions, 35 reducing their positions, and 6 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more call options, than puts
Call options by funds: $ | Put options by funds: $
more funds holding
Funds holding: →
more capital invested
Capital invested by funds: $ → $
11% less repeat investments, than reductions
Existing positions increased: 31 | Existing positions reduced: 35
Holders
80
Holding in Top 10
–
Calls
$1.55M
Puts
$709K
Top Buyers
| 1 | +$10.8M | |
| 2 | +$1.48M | |
| 3 | +$816K | |
| 4 |
SM
Sabby Management
Miami Beach,
Florida
|
+$718K |
| 5 |
ProShare Advisors
Bethesda,
Maryland
|
+$555K |
Top Sellers
| 1 | -$4.71M | |
| 2 | -$1.22M | |
| 3 | -$850K | |
| 4 |
Northern Trust
Chicago,
Illinois
|
-$601K |
| 5 |
OAM
Oxford Asset Management
Oxford,
United Kingdom
|
-$392K |